There are two major competitive advantages of KD-pharma products compared with others in the industry:
Higher economic value when comparing omega-3 to omega-3: when doctors recommend their patient to take omega-3 for their cardiovascular condition, they usually suggest 2 grams of daily omega-3 based on the suggestion made by US FDA. To achieve the volume, you would have to consume 6,000 to 8,000mg of most other omega-3 oil compared to only 2,000mg of PURE O3.
Less "unwanted material" within the fish oil: not many people think about what the rest of the materials are beside the omega-3 in the fish oil capsules. Depending on the extraction methods, there are some "unwanted materials" left in the fish oil such as omega-6, cholesterol, saturated fats and mono-unsaturated fats that can cause health problems. So consuming lesser concentrated omega-3 supplemental usually doesn't do any good to us because of those unwanted material.
Low risk of contaminant: a method comparison table (see below) shows that SCF is probably the best way to extract fish oil. KD-pharma is very experienced in this technology compared to others in the industry.
Environment friendly: KD-pharma produce almost no industrial waste while producing the fish oil concentrate.
Other advantages include high standard in quality control and safety control.
|
|
|
|
SFE / SFC
|
Distillation
(short way distillation)
|
Liquid Chromatography
|
| Use of organic solvents
|
No
|
No
|
Yes
|
| Risk of end product being contaminated with traces of organic solvents
|
No
|
No
|
Yes
|
| Oxidative stress through high temperatures
|
No (<50°C)
|
Yes (160-200°C)
|
No
|
| Risk of formation of isomers
|
No
|
Yes
|
No
|
| Risk of undesired exposure to oxygen
|
Very unlikely
|
Unlikely
|
Possible
|
| Efficient removal of contaminants (heavy metals, pesticides, sioxins, PCBs, furans, etc.)
|
Yes
|
Yes
|
Limited
|
| Sufficiently high separation selectivity to produce highly concentrated EPA and/or DHA?
|
Yes
|
No
|
Yes
|
| Environmental impact
|
Low
|
Medium
|
High
|
| 
